THE CODI Co.,Ltd. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for diseases such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy for cancer and inflammatory diseases. The company was formerly known as CODI-M Co., Ltd. and changed its name to THE CODI Co.,Ltd. in November 2022. It was incorporated in 1999 and is based in Cheonan-si, South Korea.